Pharmaceuticals, Biotechnology and Life Sciences
Company passes final release tests of scaled-up clinical grade production to supply drug product for upcoming Acclaim-1 and Acclaim-2 clinical…
Company passes final release tests of scaled-up clinical grade production to supply drug product for upcoming Acclaim-1 and Acclaim-2 clinical…
Data for datopotamab deruxtecan (DS-1062) and ENHERTU® signal strong potential of these antibody drug conjugates in advanced lung cancer New…
EDMONTON, Alberta–(BUSINESS WIRE)–#AI–48Hour Discovery Inc. (48HD) and Quantum Intelligence Corp. (QIC) announced today the establishment of a joint venture called…
Data for datopotamab deruxtecan (DS-1062) and ENHERTU® signal strong potential of these antibody drug conjugates in advanced lung cancer New…
EDMONTON, Alberta–(BUSINESS WIRE)–#AI–48Hour Discovery Inc. (48HD) and Quantum Intelligence Corp. (QIC) announced today the establishment of a joint venture called…
Marie Napoli, Partner, Napoli Shkolnik PLLC, releases new report addressing the issues of FDA-approved drugs and medical devices that may…
Data for datopotamab deruxtecan (DS-1062) and ENHERTU® signal strong potential of these antibody drug conjugates in advanced lung cancer New…
Marie Napoli, Partner, Napoli Shkolnik PLLC, releases new report addressing the issues of FDA-approved drugs and medical devices that may…
Data for datopotamab deruxtecan (DS-1062) and ENHERTU® signal strong potential of these antibody drug conjugates in advanced lung cancer New…